Abstract
The origins of autoimmunity in systemic lupus erythematosus (SLE) are thought to involve both genetic and environmental factors. To identify environmental agents that could potentially incite autoimmunity, we have traced the autoantibody response in human SLE back in time, prior to clinical disease onset, and identified the initial autoantigenic epitope for some lupus patients positive for antibodies to 60 kDa Ro. This initial epitope directly cross-reacts with a peptide from the latent viral protein Epstein-Barr virus nuclear antigen-1 (EBNA-1). Animals immunized with either the first epitope of 60 kDa Ro or the cross-reactive EBNA-1 epitope progressively develop autoantibodies binding multiple epitopes of Ro and spliceosomal autoantigens. They eventually acquire clinical symptoms of lupus such as leukopenia, thrombocytopenia and renal dysfunction. These data support the hypothesis that some humoral autoimmunity in human lupus arises through molecular mimicry between EBNA-1 and lupus autoantigens and provide further evidence to suspect an etiologic role for Epstein-Barr virus in SLE.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Arbuckle, M.R. et al. Autoantibodies are present years before the clinical onset of systemic lupus erythematosus. N. Engl. J. Med. 349, 1526–1533 (2003).
Dale, J.B. & Beachey, E.H. Epitopes of streptococcal M proteins shared with cardiac myosin. J. Exp. Med. 162, 583–591 (1985).
Olson, J.K., Croxford, J.L., Calenoff, M.A., Dal Canto, M.C. & Miller, S.D. A virus-induced molecular mimicry model of multiple sclerosis. J. Clin. Invest. 108, 311–318 (2001).
Kirvan, C.A., Swedo, S.E., Heuser, J.S. & Cunningham, M.W. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat. Med. 9, 914–920 (2003).
Levin, M.C. et al. Autoimmunity due to molecular mimicry as a cause of neurological disease. Nat. Med. 8, 509–513 (2002).
James, J.A. et al. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J. Clin. Invest. 100, 3019–3026 (1997).
James, J.A. et al. Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis Rheum. 44, 1122–1146 (2001).
Ascherio, A. et al. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA 286, 3083–3038 (2001).
McClain, M.T., Harley, J.B. & James, J.A. The role of Epstein-Barr virus in systemic lupus erythematosus. Front. Biosci. 6, e137–147 (2001).
Vaughan, J.H., Nguyen, M.D., Valbracht, J.R., Patrick, K. & Rhodes, G.H. Epstein-Barr virus-induced autoimmune responses. II. Immunoglobulin G autoantibodies to mimicking and nonmimicking epitopes. Presence in autoimmune disease. J. Clin. Invest. 95, 1316–1327 (1995).
McClain, M.T., Rapp, E.C., Harley, J.B. & James, J.A. Infectious mononucleosis patients temporarily recognize a unique, cross-reactive epitope of Epstein-Barr virus nuclear antigen-1. J. Med. Virol. 70, 253–257 (2003).
Sabbatini, A., Bombardieri, S. & Migliorini, P. Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of SmD and Epstein-Barr virus-encoded nuclear antigen EBNA I. Eur. J. Immunol. 23, 1146–1152 (1993).
James, J.A. & Harley, J.B. Linear epitope mapping of an Sm B/B′ polypeptide. J. Immunol. 148, 2074–2079 (1992).
James, J.A., Scofield, R.H. & Harley, J.B. Lupus humoral autoimmunity after short peptide immunization. Ann. NY Acad. Sci. 5, 124–127 (1997).
Riemekasten, G. et al. A novel epitope on the C-terminus of Sm D1 is recognized by the majority of sera from patients with systemic lupus erythematosus. J. Clin. Invest. 102, 754–763 (1998).
Arbuckle, M.R., Reichlin, M., Harley, J.B. & James, J.A. Shared early autoantibody recognition events in the development of anti-Sm B/B′ in human lupus. Scand. J. Immunol. 50, 447–455 (1999).
Huang, S.C., Scofield, R.H. & Harley, J.B. Human anti-Ro autoantibodies bind multiple conformational epitopes of 60 kDa Ro autoantigen. J. Clin. Immunol. 156, 4059–4066 (1997).
Scofield, A.N., Kurien, B.T., Gordon, T.P. & Scofield, R.H. Can B cell epitopes of 60 kDa Ro distinguish systemic lupus erythematosus from Sjögren's syndrome? Lupus 10, 547–553 (2001).
Routsias, J.G. et al. Structural, molecular and immunological properties of linear B-cell epitopes of Ro 60 KD autoantigen. Scand. J. Immunol. 47, 280–287 (1998).
McClain, M.T. et al. Structural availability influences the capacity of autoantigenic epitopes to induce a widespread lupus-like autoimmune response. Proc. Natl. Acad. Sci. USA 101, 3551–3556 (2004).
McClain, M.T., Ramsland, P.A., Kaufman, K.M. & James, J.A. Anti-Sm autoantibodies in systemic lupus target highly basic surface structures of complexed spliceosomal autoantigens. J. Immunol. 168, 2054–2062 (2002).
McClain, M.T., Scofield, R.H., Kurien, B.T., Gross, T.F. & James, J.A. Selective small antigenic structures are capable of inducing widespread autoimmunity which closely mimics the humoral fine specificity of human SLE. Scand. J. Immunol. 56, 399–407 (2002).
Deshmukh, U.S. et al. Ro60 peptides induce antibodies to similar epitopes shared among lupus–related autoantigens. J. Immunol. 164, 6655–6661 (2000).
Deshmukh, U.S. et al. Immune responses to Ro60 and its peptides in mice. I. The nature of the immunogen and endogenous autoantigen determine the specificities of the induced autoantibodies. J. Exp. Med. 189, 531–540 (1999).
Thompson, M.P. & Kurzrock, R. Epstein-Barr virus and cancer. Clin. Cancer Res. 10, 803–821 (2004).
Harley, J.B. & James, J.A. Is there a role for Epstein-Barr virus in Lupus? The Immunologist 6, 79–83 (1998).
Kong, P.L. et al. Intrinsic T cell defects in systemic autoimmunity. Ann. NY Acad. Sci. 987, 60–67 (2003).
Goodnow, C.C. Balancing immunity and tolerance: deleting and tuning lymphorepertoires. Proc. Natl. Acad. Sci. USA 93, 2264–2271 (1996).
Kang, I. et al. Defective control of latent Epstein–Barr virus infection in systemic lupus erythematosus. J. Immunol. 172, 1287–1294 (2004).
Hochberg, M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 40, 1725 (1998).
Acknowledgements
The authors thank J. Vaughan for the infectious mononucleosis sera, M. Reichlin and the Oklahoma Clinical Immunology Laboratory for SLE patient sera, T. Gross, Y. Akbarali, B. Bruner and T. Bruner for their technical assistance, and X. Kim for statistical analysis. This work has been supported by the US National Institutes of Health grants (AI31584, AR45451, AI47575, AR48045, AI53747, AI54117, AR45084, AR45231, AR42460, AR48940, AI24717, RR20143, RR15577, RR14467, and DE015223), the Presbyterian Health Foundation and the US Department of Veterans Affairs. The opinions and assertions contained herein are private views of the authors and are not to be construed as official or as reflecting the views of the US Army, Navy or the Department of Defense.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
McClain, M., Heinlen, L., Dennis, G. et al. Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat Med 11, 85–89 (2005). https://doi.org/10.1038/nm1167
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm1167